Patient characteristicsa

Characteristic
Total No. of patients29
Age (yr)52.1 ± 17.1 (18–84)
Sex (male/female)20:9
No. of enhanced MRI scansb10.1 ± 3.2 (6–18)
Cumulative dose (mL)b175.2 ± 59.1 (76–316)
Interval (days) between 1st and final MRI658.5 ± 250.5 (154–1154)
DiagnosesIntracranial metastases (n = 10), primary brain neoplasm (n = 11), meningioma (n = 3), melanomas (n = 3), unknown lesion (n = 2)

  • ↵a Data are mean ± SD, with the range in parentheses.

  • ↵b Does not include the last MRI used for measurement.